Intranasal NGF in pediatric brain injury: the dawn of neurorepair?
Keywords:
NGF, brain injury, pediatricReferences
Di Sarno L, Curatola A, Cammisa I, et al. Non-pharmacologic approaches to neurological stimulation in patients with severe brain injuries: a systematic review. Eur Rev Med Pharmacol Sci. 2022;26(18):6856-6870. doi: 10.26355/eurrev_202209_29789.
Chiaretti A, Eftimiadi G, Buonsenso D, Rendeli C, Staccioli S, Conti G. Intranasal nerve growth factor administration improves neurological outcome after GBS meningitis. Childs Nerv Syst. 2020;36(9):2083-2088. doi: 10.1007/s00381-020-04590-x.
Di Sarno L, Ferretti S, Capossela L, et al. Neurofunctional and Clinical Effects of Intranasal Human Recombinant Nerve Growth Factor in Children with Acquired Brain Injury. Pharmaceuticals. 2026;19(4):590. doi: 10.3390/ph19040590.
Gatto A, Capossela L, Conti G, et al. Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome. Biol Direct. 2023;18(1):61. doi: 10.1186/s13062-023-00418-1.
Di Sarno L, Capossela L, Ferretti S, et al. Intranasal Human-Recombinant Nerve Growth Factor Enhances Motor and Cognitive Function Recovery in a Child with Severe Traumatic Brain Injury. Pharmaceuticals. 2025;18(2):163. doi: 10.3390/ph18020163.
Capossela L, Graglia B, Ferretti S, et al. Intranasal human-recombinant nerve growth factor administration improves cognitive functions in a child with severe traumatic brain injury. Eur Rev Med Pharmacol Sci. 2024;28(18):4302-4312. doi: 10.26355/eurrev_202409_36790.
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

